rs1159327 — ESR1 ESR1 intron variant

ESR1 Intron Variant — Estrogen Receptor Expression and Bone Health

The ESR1 gene encodes estrogen receptor alpha (ERα), the primary nuclear receptor through which estrogen orchestrates bone remodeling, reproductive function, and metabolism. ERα is expressed throughout the skeleton, uterus, ovary, breast, and cardiovascular system — making ESR1 variants some of the most broadly consequential polymorphisms in reproductive-age women. The rs1159327 variant sits deep within an ESR1 intron on chromosome 6 (position 151,726,887 GRCh38) and has been identified at genome-wide significance for bone mineral density¹¹ identified at genome-wide significance for bone mineral density
He et al. Osteoporosis International 2023, n=141,261 UK Biobank participants, p=5×10⁻⁹.

The Mechanism

As an intronic variant, rs1159327 does not alter the ESR1 protein sequence. Instead, it likely influences gene expression through one of several regulatory mechanisms common to intronic SNPs: disruption of transcription factor binding sites²² transcription factor binding sites
protein complexes that bind DNA and control when and how much a gene is transcribed, alteration of enhancer activity, or effects on mRNA splicing efficiency. The ESR1 gene is large (~300 kb) with numerous regulatory elements distributed across its introns, and the intron 1 region in particular has been repeatedly implicated in controlling receptor expression levels.

ERα regulates osteoblast (bone-forming cell) proliferation and survival while suppressing osteoclast (bone-resorbing cell) activity. When ERα expression or sensitivity is reduced — as intronic regulatory variants can cause — the balance tips toward net bone resorption. The T allele at rs1159327 is associated with lower average bone mineral density, consistent with a model in which reduced ESR1 expression impairs estrogen's bone-protective signaling.

The Evidence

The primary evidence linking rs1159327 to bone health comes from a 2023 longitudinal GWAS in the UK Biobank³³ 2023 longitudinal GWAS in the UK Biobank
He et al., Osteoporosis International, n=141,261, which used trajectory analysis (TrajGWAS) to model heel bone mineral density over time. The ESR1 locus emerged at genome-wide significance (p=5×10⁻⁹) for BMD mean, placing rs1159327 among a handful of ESR1-region variants robustly associated with skeletal health in large populations.

This finding sits within a rich broader literature on the ESR1 locus. A meta-analysis of GWAS in premenopausal women⁴⁴ A meta-analysis of GWAS in premenopausal women
Koller et al. JBMR 2013, discovery n=4,061 + replication n=5,597 identified multiple independent signals in the ESR1 region, and a separate GWAS in 2,468 European men⁵⁵ a separate GWAS in 2,468 European men
Holliday et al. PLoS One 2011 confirmed the 6q25 locus affects both calcaneal ultrasound BMD and radial volumetric BMD. The largest early meta-analysis — 18,917 individuals across 8 European centers⁶⁶ 18,917 individuals across 8 European centers
Ioannidis et al. JAMA 2004 — found that ESR1 variants affect fracture risk by mechanisms independent of baseline bone density, suggesting the estrogen receptor pathway influences bone quality and geometry as well as mass.

Population data from dbSNP (ALFA) shows the T allele frequency varies from ~17% in South Asian populations to ~45% in African populations, meaning TT homozygosity (~8% globally) is substantially rarer in South/East Asian ancestry groups but more common in individuals of African descent.

Practical Implications

The most direct implications of the T allele relate to bone health across the lifespan. Carriers of one or two T alleles have a tendency toward lower bone mineral density, which translates to heightened importance of bone-protective behaviors — particularly weight-bearing exercise, calcium intake, vitamin D sufficiency, and proactive bone density monitoring. The effect of ESR1 variants on fracture risk appears to operate partly independently of BMD, which means a normal DEXA scan does not fully reassure against elevated fracture risk in T allele carriers.

For women, the ESR1 locus is also relevant to reproductive outcomes. Although the strongest fertility associations in ESR1 involve the nearby intron-1 variants rs2234693 (PvuII) and rs9340799 (XbaI), these three variants are in linkage disequilibrium and likely index overlapping biology. ESR1 polymorphisms have been examined in endometriosis, IVF outcomes, and ovarian reserve studies — the receptor's role in folliculogenesis, endometrial receptivity, and implantation means that even modest changes in expression can influence reproductive efficiency.

Interactions

rs1159327 sits near two of the most studied ESR1 variants: rs2234693 (PvuII, intron 1) and rs9340799 (XbaI, intron 1). These three variants span a regulatory stretch of ESR1 and are in partial linkage disequilibrium — meaning carriers of the rs1159327 T allele are more likely to also carry the rs2234693 T allele and rs9340799 G allele. Haplotype analyses of the ESR1 region show that combined effects on bone, cardiovascular, and hormone-responsive tissues can differ substantially from any single variant's individual contribution. Individuals carrying T alleles at multiple ESR1 loci may have more pronounced reductions in receptor expression.